Publications by authors named "Uri Ladror"

Claim this Profile
E
Empowering therapeutic antibodies with IFN-α for cancer immunotherapy.
Jun Guo, Yu Xiao, Ramesh Iyer, Xin Lu, Marc Lake, Uri Ladror

PLoS One· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand association rates to the inner-variable-domain of a dual-variable-domain immunoglobulin are significantly impacted by linker design.
Enrico L Digiammarino, John E Harlan, Karl A Walter, Uri S Ladror, Rohinton P Edalji

MAbs· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.
Xuesong Liu, Yan Shi, David X Maag, Joann P Palma, Melanie J Patterson, Uri S Ladror

Clin Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent and selective Bcl-2 inhibitor using SAR by NMR.
Andrew M Petros, Jeffrey R Huth, Thorsten Oost, Cheol-Min Park, Hong Ding, Uri Ladror

Bioorg Med Chem Lett· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonance.
Jeffrey R Huth, Danying Song, Renaldo R Mendoza, Candice L Black-Schaefer, Jamey C Mack, Uri S Ladror

Chem Res Toxicol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies.
Jeffrey R Huth, Chang Park, Andrew M Petros, Aaron R Kunzer, Michael D Wendt, Uri S Ladror

Chem Biol Drug Des· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies.
Wen-Zhen Gu, Ingrid Joseph, Yi-Chun Wang, David Frost, Gerard M Sullivan, Uri S Ladror

Anticancer Drugs· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the anti-apoptotic mechanism of Bcl-B.
Dayong Zhai, Ning Ke, Haichao Zhang, Uri Ladror, Mary Joseph

Biochem J· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis